SEC Filing Summary: Ra Medical Systems, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Ra Medical Systems, Inc. on October 1, 2018. The filing reports on corporate governance changes and the closing of the company's Initial Public Offering (IPO). Note: The input metadata referenced "Catheter Precision, Inc.," but the filing text explicitly identifies the registrant as Ra Medical Systems, Inc.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document focuses on corporate events rather than financial performance data.
Material Changes
- IPO Closing: The company completed its IPO, selling 4,485,000 shares of common stock. This total includes 585,000 shares sold pursuant to the full exercise of the underwriters' option to purchase additional shares.
- Corporate Governance: The company filed an amended and restated certificate of incorporation and adopted amended and restated bylaws, effective immediately prior to the IPO closing.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on future performance, or specific risk factors within this text. It references the company's Prospectus (filed September 27, 2018) for detailed descriptions of risk factors and capital stock.
Investor Verification Checklist
- Verify the final IPO share count and offering price in the attached press release (Exhibit 99.1).
- Review the full text of the Amended and Restated Certificate of Incorporation (Exhibit 3.1) and Bylaws (Exhibit 3.2) for specific governance terms.
- Consult the Form S-1 Registration Statement (No. 333-226191) for detailed financial statements and risk factors not included in this 8-K.